Clinical Trials Browser

Phase 2 × Radiosurgery × Genitourinary × Clear all

NCT02713269 2026-04-17

Thermal Ablation and Spine Stereotactic Radiosurgery in Treating Patients With Spine Metastases at Risk for Compressing the Spinal Cord

Phase 2 Active not recruiting

DermatologicGastrointestinalGenitourinaryHead & NeckSarcoma

Carcinoma, Renal Cell, Gastrointestinal Neoplasms, Melanoma, Neoplasms, Unknown Primary, Sarcoma, Spinal Cord Compression, Thyroid Neoplasms

NCT05616650 2026-04-16

Focal Therapy With Stereotactic Body Radiation Therapy (SBRT) for Patients With a Single Prostate Tumor

Phase 2 Recruiting

Prostatic Neoplasms

NCT03575611 2026-04-15

Stereotactic Body Radiation Therapy in Treating Patients With Oligometastatic Renal Cell Carcinoma

Phase 2 Suspended

Carcinoma, Renal Cell

NCT03361735 2026-04-09

Radium Ra 223 Dichloride, Hormone Therapy and Stereotactic Body Radiation Therapy in Treating Patients With Metastatic Prostate Cancer

Phase 2 Active not recruiting

25 enrolled 10 charts

Prostate Adenocarcinoma

NCT05053152 2026-04-08

Testing the Addition of the Drug Relugolix to the Usual Radiation Therapy for Advanced-Stage Prostate Cancer, The NRG Promethean Study

Phase 2 Active not recruiting

Prostatic Neoplasms

NCT05361798 2026-04-06

A Phase II Study Evaluating T-Cell Clonality After Stereotactic Body Radiation Therapy Alone and in Combination With the Immunocytokine PDS01ADC in Localized High and Intermediate Risk Prostate Cancer Treated With Androgen Deprivation Therapy

Phase 2 Recruiting

Prostatic Neoplasms

NCT03795207 2026-03-31

POSTCARD

Phase 2 Active not recruiting

Node; Prostate

NCT03436654 2026-03-27

Multi-arm Multi-modality Therapy for Very High Risk Localized and Low Volume Metastatic Prostatic Adenocarcinoma

Phase 2 Active not recruiting

Prostatic Neoplasms

NCT07470840 2026-03-24

SBRT Plus Anlotinib and Bimepolizumab in Locally Advanced or Metastatic Renal Cell Carcinoma

Phase 2 Not yet recruiting

Carcinoma, Renal Cell

NCT07451795 2026-03-05

SHARP

Phase 2 Recruiting

Prostatic Neoplasms

NCT06835725 2026-02-27

ADAPT-25

Phase 2 Recruiting

Prostate CA

NCT07414992 2026-02-17

A Study of Radiation Therapy and Cemiplimab With or Without Fianlimab In People With Bladder Cancer

Phase 2 Not yet recruiting

Urinary Bladder Neoplasms

NCT05320406 2026-02-12

REVELUTION

Phase 2 Active not recruiting

94 enrolled 13 charts

Prostatic Neoplasms

NCT07393867 2026-02-06

ARPEGGIO

Phase 2 Not yet recruiting

Prostatic Neoplasms

NCT03902951 2026-02-05

Antiandrogen Therapy and SBRT in Treating Patients With Recurrent, Metastatic Prostate Cancer

Phase 2 Active not recruiting

Prostatic Neoplasms

NCT03796767 2026-01-28

SOAR

Phase 2 Active not recruiting

20 enrolled 26 charts

Lymphatic Metastasis, Prostatic Neoplasms

NCT06397703 2026-01-28

ADT and SBRT vs SBRT Alone for Unfavorable Intermediate Risk Prostate Cancer

Phase 2 Recruiting

Prostatic Neoplasms

NCT04402151 2026-01-26

PSMA SBRT-SIB

Phase 2 Recruiting

Prostatic Neoplasms

NCT03503344 2026-01-21

PILLAR

Phase 2 Completed

26 enrolled 11 charts

Castration Levels of Testosterone

NCT05038332 2026-01-16

Post-prostatectomy Radiation Therapy--Moderate Versus Ultra-hypofractionated (Also Known as Stereotactic Body Radiation Therapy [SBRT])

Phase 2 Recruiting

Prostatic Neoplasms

NCT05830058 2026-01-05

Positron Emission Tomography (PET) Guided Stereotactic Body Radiation Therapy for the Treatment of Oligoprogressive Non-small Cell Lung Cancer, Melanoma, and Renal Cell Carcinoma

Phase 2 Recruiting

DermatologicGenitourinaryThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Melanoma

NCT06378866 2025-12-26

DIVINE

Phase 2 Recruiting

Prostatic Neoplasms

NCT03007732 2025-12-05

Pembrolizumab +/- SD-101 in Hormone-Naïve Oligometastatic Prostate Cancer With RT and iADT

Phase 2 Completed

23 enrolled 14 charts

Prostatic Neoplasms

NCT04974671 2025-12-04

Trial Of Stereotactic Body Radiation Therapy (SBRT) for Oligoprogression on Immune Checkpoint Inhibitors (ICI) in Metastatic Renal Cell Carcinoma

Phase 2 Recruiting

Carcinoma, Renal Cell, Disease Progression

NCT05893381 2025-12-03

LUST

Phase 2 Recruiting

Prostatic Neoplasms

NCT03541850 2025-11-06

Stereotactic Body Radiation Therapy in Treating Patients With Localized Prostate Cancer That Have Undergone Surgery

Phase 2 Active not recruiting

PSA Level Greater Than 0.03

NCT05241340 2025-10-24

RAD-VACCINE

Phase 2 Active not recruiting

Urinary Bladder Diseases, Urinary Bladder Neoplasms, Urologic Diseases, Urologic Neoplasms

NCT03693014 2025-10-06

A Study of Several Radiation Doses for Patients With Progression on Immunotherapy/Checkpoint Inhibitors

Phase 2 Active not recruiting

GenitourinaryThoracic

Urinary Bladder Neoplasms, Kidney Neoplasms, Lung Neoplasms, Neoplasm Metastasis

NCT06927635 2025-09-05

SECURE

Phase 2 Recruiting

Castrate Resistance Prostate Cancer

NCT06255223 2025-09-03

A Study of Multimodal Radiotherapy for Renal Cell Carcinoma Progressed After Prior Immunotherapy

Phase 2 Recruiting

Carcinoma, Renal Cell

NCT07152067 2025-09-03

TOPPGUN-RS

Phase 2 Not yet recruiting

Prostatic Neoplasms

NCT04936230 2025-08-17

Immunotherapy With or Without Radiation Therapy for Metastatic Urothelial Cancer

Phase 2 Terminated

1 enrolled 1 chart

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell

NCT04090710 2025-08-03

CYTOSHRINK

Phase 2 Active not recruiting

Carcinoma, Renal Cell

NCT03298087 2025-08-01

Systemic and Tumor-Directed Therapy for Oligometastatic Prostate Cancer

Phase 2 Completed

28 enrolled 10 charts

Newly Diagnosed Oligometastatic Prostate Cancer

NCT04915508 2025-06-22

EXCALIBUR

Phase 2 Recruiting

Prostatic Neoplasms

NCT05915442 2025-05-20

SBRT-AMICO

Phase 2 Recruiting

Oligometastatic Prostate Cancer

NCT05496959 2025-05-13

LUNAR

Phase 2 Active not recruiting

Prostatic Neoplasms

NCT05169970 2025-05-08

A Study of Stereotactic Body Radiation Therapy (SBRT) Without Androgen Deprivation Therapy (ADT) in People With Unfavorable Intermediate-Risk Prostate Cancer

Phase 2 Recruiting

Prostatic Neoplasms

NCT04262154 2025-04-27

Study of Abiraterone Acetate or Enzalutamide, Atezolizumab, GnRH Analog and Radiation Therapy in Men With Newly Diagnosed Hormone-sensitive Prostate Cancer

Phase 2 Active not recruiting

Prostatic Neoplasms

NCT06201078 2025-03-13

PROSTARE

Phase 2 Recruiting

Local Recurrence of Malignant Tumor of Prostate

NCT04580836 2024-10-26

MRI-Guided Radiation Therapy for the Treatment of Early-Stage Kidney Cancer, the MRI-MARK Trial

Phase 2 Withdrawn

Carcinoma, Renal Cell

NCT05655715 2024-10-16

CheckPRO

Phase 2 Completed

Neoplasms, Prostatic Neoplasms

NCT02978404 2024-06-28

Combining Radiosurgery and Nivolumab in the Treatment of Brain Metastases

Phase 2 Completed

CNSDermatologicGenitourinaryThoracic

Clear-cell metastatic renal cell carcinoma, Brain Neoplasms, Melanoma, Small Cell Lung Carcinoma

NCT06251492 2024-02-20

Radiation and Adebrelimab in Prostate Cancer With Imaging-measurable Disease (RAPID)

Phase 2 Unknown

Prostate Cancer Metastatic

NCT03511391 2024-01-23

CHEERS

Phase 2 Completed

DermatologicGenitourinaryHead & NeckThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Head and Neck Neoplasms, Melanoma

NCT00003308 2023-06-22

Radiation Therapy in Treating Patients With Newly Diagnosed Brain Metastases From Kidney Cancer, Melanoma, or Sarcoma

Phase 2 Completed

CNSDermatologicGenitourinaryGynecologicSarcoma

Brain Neoplasms, Carcinoma, Renal Cell, Chondrosarcoma, Kidney Neoplasms, Melanoma, Neoplasm Metastasis, Ovarian Neoplasms, Sarcoma, Osteosarcoma, Neuroectodermal Tumors, Primitive, Peripheral

NCT02680587 2022-11-29

ORIOLE

Phase 2 Completed

80 enrolled 12 charts

Prostatic Neoplasms

NCT05212857 2022-03-16

Enhanced Systemic Combined With Local Treatment for Primary and Metastatic Lesions in Oligo-metastatic Prostate Cancer

Phase 2 Unknown

Prostatic Neoplasms

NCT02599779 2021-09-01

OZM-065

Phase 2 Completed

Carcinoma, Renal Cell

NCT01896271 2021-08-23

High Dose IL-2 and Stereotactic Ablative Body Radiation Therapy for Metastatic Renal Cancer

Phase 2 Completed

30 enrolled 12 charts

Clear-cell metastatic renal cell carcinoma, Kidney Neoplasms, Neoplasm Metastasis